A REVIEW: ANALYSIS OF MICROBIOME DIVERSITY IN CANCER

Authors

  • Norma Nur Azizah Bioinformatics, Biomedical Science Magister Program, Faculty of Medicine Universitas Indonesia, Jakarta, 10430, Indonesia
  • Ade Arsianti Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia
  • Linda Erlina Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia

DOI:

https://doi.org/10.11594/bbrj.04.02.03

Keywords:

Microbiome, cancer, targeted sequencing, metagenomics, diversity

Abstract

There have been many studies linking the microbiome to disease, including cancer. The microbiome is all the genetic material in the form of bacteria, fungi, or viruses that exists in parts of the human body. The microbiome is reported to trigger cancer due to the presence of certain pathogenic microbes or the presence of dysbiosis. Therefore, it is necessary to analyze the diversity of the microbiome to see the relationship. Metagenomics is the latest technology that can be used to analyze the diversity of the microbiome in cancer. There are two approaches in metagenomic analysis, namely targeted sequencing and sequencing of the entire metagenome. This paper will discuss a targeted sequencing metagenomic approach for the identification of microbial diversity in cancer.

Downloads

Download data is not yet available.

References

1. WHO. Cancer [Internet]. Geneva: WHO. 2017. [dikun- jungi pada 2021 Feb 17]. Tersedia dari: http://www.who.int/mediacentre/fact- sheets/fs297/en/.

2. KEMENKES.Jenis Kanker Rentan Menyerang Manusia. [Internet]. Jakarta: Kemenkes.2020. [dikunjungi pada 2021 Feb 17]. Tersedia dari https://www.kemkes.go.id/arti- cle/view/20011400002/jenis-kanker-ini-rentan-me- nyerang-manusia.html

3. Lee KA, Luong MK, Shaw H, Nathan P, Bataille V, Spec- tor TD. The gut microbiome: what the oncologist ought to know. British Journal of Cancer [Internet]. 2021; Available from: https://doi.org/10.1038/s41416-021-01467-x

4. Mukesh Verma. Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epide- miology. SAGE Journal [Internet].2016: Available from: https://doi.org: 10.1177/1533034616645219

5. Riesenfeld CS, Schloss P, Handelsman J (2004) Meta- genomics: Genomic analysis of microbial communi- ties. Annu Rev Genet 38: 525–552.

6. Consortium, H. M. P. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).

7. O’Hara, A. M. & Shanahan, F. The gut flora as a forgot- ten organ. EMBO Rep. 7, 688–693 (2006).

8. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012)

9. Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013).

10. Li, Y. et al. Gut microbiota accelerate tumor growth via cjun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 33, 1231–1238 (2012)

11. Robert F. Schwabe and Christian Jobin. The Microbiome and Cancer. Nature Reviews Cancer.[Inter- net].2013. available from: doi:10.1038/nrc3610

12. Fox, J. G. & Wang, T. C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117, 60–69 (2007).

13. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., Jia W., Cai S., Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volun- teers. ISME J. 2011; 6:320–329. DOI:

10.1038/ismej.2011.109.

14. Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The Microbiota of Breast Tissue and Its Association with Breast Cancer. Environmental Microbiology Appl. (2016) 82:5039–48. DOI:

10.1128/AEM.01235-16

15. Zahra Eslami, Keivan MAzidjadeh, Sina Halvaei, Fatemeh Babapirali, Rezvan Esmaeili. Microbiome and Breast Cancer: New Role and for Ancient Population. Fron Oncol.2020.10(120).

16. Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. (2016) 6:30751. DOI:10.1038/srep30751

17. Gencore. Metagenomic.[Internet].[dikunjungi pada 2021 Nov 15]. Dapat di akses pada:https://learn.gencore.bio.nyu.edu/metgenomics/

18. Unterseher, Martin, Jumpponen, Ari, Öpik, Maarja, Tedersoo, Leho, Moora, Mari, Dormann, Carsten F., et al. Species abundance distributions and richness estimations in fungal metagenomics - Lessons learned from community ecology. Molecular Ecology. 2011.20(2), p. 275–285.

19. EzbioCloud. 16S RRNA and 16S RRNA.[Internet].2017. [dikunjungi pada 2021 Nov 15]. Dapat diakses pada: https://help.ezbiocloud.net/16s-rrna-and-16s-rrna- gene/

20. Karel Sedlar. Methods For Comparative Analysis Of Metagenomic Data. Research gate. 2019. DOI: 10.13140/RG.2.2.12388.42882

21. Bolger, Anthony M, Lohse, Marc and Usadel, Bjoern. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014. 30(15), p. 2114–2120

22. Esling, Philippe, Lejzerowicz, Franck and Pawlowski, Jan. Accurate multiplexing and filtering for high- throughput amplicon-sequencing. Nucleic Acids Re- search. 2015. 43(5), p. 2513– 2524

23. Navas-molina, José A., Peralta-Sánchez, Juan M., Gon- zález, Antonio, Mcmurdie, Paul J., Vázquez-Baeza, Yo- shiki, XU, Zhenjiang, et al. Advancing our understand- ing of the human microbiome using QIIME. In : Methods in Enzymology. 2013. P. 371–444. ISBN 9780124078635.

24. BIOMCARE. Key term in microbiome projects [Inter- net]. 2019. [dikunjungi pada 2021 Nov 22]. dapat di- akses pada: https://biomcare.com/info/key-terms- in-microbiome-projects/

25. Alan Smith, at al. Distinct microbial communities that differ by race, stage, or breast tumor subtype in breast tissues of non-Hispanic Black and nonHispanic White women. Nature. 2019. 9:11940.

26. Thyagarajan, S., Zhang, Y., Thapa, S. et al. Comparative analysis of racial differences in breast tumor microbiome. SciRep 10, 14116 (2020). https://doi.org/10.1038/s41598-020-71102-x.

27. Jain, M., & Yadav, R. (2022). Metagenomics Analysis of Breast Cancer to Study Bacterial Diversity. Journal of Drug Delivery and Therapeutics, 12(2-S), 119–126. https://doi.org/10.22270/JDDT.V12I2-S.5433

Downloads

Published

2025-07-23

How to Cite

[1]
Norma Nur Azizah, Ade Arsianti, and Linda Erlina, “A REVIEW: ANALYSIS OF MICROBIOME DIVERSITY IN CANCER”, Bioinform. Biomed. Res. J. , vol. 4, no. 2, pp. 57–69, Jul. 2025, doi: 10.11594/bbrj.04.02.03.